| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.059 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.16 | 0.5 |